Lower-dose valganciclovir for the prevention of cytomegalovirus after solid organ transplantation: an important tradeoff

被引:3
作者
Arasaratnam, R. J. [1 ]
机构
[1] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA
关键词
valganciclovir; cytomegalovirus infection;
D O I
10.1111/tid.12397
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:623 / 624
页数:2
相关论文
共 2 条
[1]   Cytomegalovirus in Solid Organ Transplantation [J].
Razonable, R. R. ;
Humar, A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 :93-106
[2]   Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis [J].
Stevens, D. R. ;
Sawinski, D. ;
Blumberg, E. ;
Galanakis, N. ;
Bloom, R. D. ;
Trofe-Clark, J. .
TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) :163-173